Effects on lipomobilisation of the beta-adrenergic blocking drugs, propranolol and INPEA.
D000818:Animals; D004336:Drug Antagonism; D005227:Fatty Acids / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D013565:Sympatholytics; D010643:Phenoxybenzamine; D012110:Reserpine; D011433:Propranolol; D009638:Norepinephrine